M. George Cherian

M. George Cherian's AcademicInfluence.com Rankings

M. George Cherian

Biology

#9040

World Rank

#12197

Historical Rank

Biotechnology

#116

World Rank

#118

Historical Rank

biology Degrees

Download Badge

Biology

M. George Cherian's Degrees

PhD Biomedical Sciences University of California, Berkeley
Masters Biotechnology Stanford University

Why Is M. George Cherian Influential?

(Suggest an Edit or Addition)

(See a Problem?)

M. George Cherian's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. (2007) (639)
Metallothioneins in human tumors and potential roles in carcinogenesis. (2003) (436)
Methallothioneins and their role in the metabolism and toxicity of metals. (1978) (379)
INCREASED DIETARY CADMIUM ABSORPTION IN MICE AND HUMAN SUBJECTS WITH IRON DEFICIENCY (1978) (313)
Comparison of metallothionein determination by polarographic and cadmium-saturation methods. (1982) (227)
Clearance of mercury (HG-197, HG-203) vapor inhaled by human subjects. (1976) (225)
Cadmium-metallothionein-induced nephropathy. (1976) (224)
Toxicology of Metals (1995) (223)
The induced synthesis of metallothionein in various tissues of rat in response to metals. I. Effect of repeated injection of cadmium salts. (1981) (223)
Quantification of metallothioneins by a silver-saturation method. (1986) (222)
Metallothionein in radiation exposure: its induction and protective role. (1999) (199)
Metallothioneins in brain--the role in physiology and pathology. (1997) (197)
Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. (1982) (177)
Nuclear localization of metallothionein during cell proliferation and differentiation. (2000) (175)
Changes in the intracellular accumulation and distribution of metallothionein in rat liver and kidney during postnatal development. (1983) (171)
Essentiality, toxicology and chelation therapy of zinc and copper. (2005) (159)
The induced synthesis of metallothionein in various tissues of rats in response to metals. II. Influence of zinc status and specific effect on pancreatic metallothionein. (1982) (144)
Radioactive mercury distribution in biological fluids and excretion in human subjects after inhalation of mercury vapor. (1978) (143)
Cellular adaptation in metal toxicology and metallothionein. (1983) (143)
Role of metallothionein in carcinogenesis. (1994) (142)
THE SECRETORY PATHWAYS OF RAT SERUM GLYCOPROTEINS AND ALBUMIN (1972) (137)
Immunohistochemical localization of metallothionein in human thyroid tumors. (1987) (124)
Metabolism of intravenously injected cadmium-binding protein. (1975) (119)
Metallothionein and Liver Cell Regeneration (2006) (117)
Protective roles of metallothionein and glutathione in hepatotoxicity of cadmium. (1992) (116)
The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. (1994) (112)
The search for chelate antagonists for chronic cadmium intoxication. (1990) (110)
Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats. (1993) (108)
Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells (2005) (107)
Binding of manganese in human and rat plasma. (1985) (105)
Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. (1995) (99)
Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications. (2008) (98)
Interaction of Endothelin-1 with Vasoactive Factors in Mediating Glucose-Induced Increased Permeability in Endothelial Cells (2000) (97)
Hepatic Metallothionein as a Source of Zinc and Cysteine during the First Year of Life (1988) (95)
Biliary excretion of cadmium in rat. I. Dose-dependent biliary excretion and the form of cadmium in the bile. (1977) (95)
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. (1994) (94)
Ascorbic acid and EDTA treatment of lead toxicity in rats. (1979) (90)
Isolation and purification of cadmium binding proteins from rat liver. (1974) (89)
Quantification of metallothionein by silver saturation. (1991) (88)
Interaction of metallothionein with tumor suppressor p53 protein (2006) (87)
Gastrointestinal absorption of cadmium and metallothionein. (1991) (86)
Arsenic induces and enhances rat hepatic metallothionein production in vivo. (1992) (84)
Zinc-metallothionein protects from DNA damage induced by radiation better than glutathione and copper- or cadmium-metallothioneins. (2003) (84)
Toxicological significance of metallothionein. (1991) (81)
Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals. (1995) (79)
National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. (1993) (78)
Biochemical changes in rat kidney on exposure to elemental mercury vapor: effect on biosynthesis of metallothionein. (1976) (77)
Determination of metallothionein in tissues by cadmium-hemoglobin affinity assay. (1991) (77)
Gastrointestinal absorption and organ distribution of oral cadmium chloride and cadmium-metallothionein in mice. (1978) (75)
Potential role of p53 on metallothionein induction in human epithelial breast cancer cells (2002) (71)
Inhibition of extracellular signal regulated kinase (ERK) leads to apoptosis inducing factor (AIF) mediated apoptosis in epithelial breast cancer cells: The lack of effect of ERK in p53 mediated copper induced apoptosis (2005) (70)
Protective effects of metallothionein on streptozotocin-induced diabetes in rats. (1994) (67)
Metallothionein levels in liver and kidney of Canadians--a potential indicator of environmental exposure to cadmium. (1986) (67)
Increased expression of tissue inhibitor of metalloproteinases (TIMP-I) and metallothionein in murine lungs after hyperoxic exposure. (1994) (66)
Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. (1993) (65)
Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats. (2000) (64)
Metallothionein synthesis and localization in relation to metal storage in rat liver during gestation. (1985) (63)
A review of cinnabar (HgS) and/or realgar (As4S4)-containing traditional medicines. (2018) (60)
P53 mediated regulation of metallothionein transcription in breast cancer cells (2007) (59)
The metallothionein-null phenotype is associated with heightened sensitivity to lead toxicity and an inability to form inclusion bodies. (2002) (58)
Metabolism of orally administered cadmium-metallothionein in mice. (1979) (58)
Cellular localization of metallothionein in human term placenta. (1992) (57)
Roles of vitamin C in radiation-induced DNA damage in presence and absence of copper. (2001) (56)
Studies on the synthesis and metabolism of zinc-thionein in rats. (1977) (56)
Mobilization of hepatic cadmium in pregnant rats. (1993) (56)
Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. (1991) (55)
Organ-specific metallothionein induction in mice by X irradiation. (1989) (54)
The influence of manganese on the distribution of essential trace elements. II. The tissue distribution of manganese, magnesium, zinc, iron, and copper in rats after chronic manganese exposure. (1983) (54)
Cadmium-induced enteropathy: comparative toxicity of cadmium chloride and cadmium-thionein. (1976) (53)
Protective role of zinc-metallothionein on DNA damage in vitro by ferric nitrilotriacetate (Fe-NTA) and ferric salts. (1998) (52)
Induction of metallothionein synthesis by zinc in cadmium pretreated rats. (1990) (52)
Differential regulation of signal transduction pathways in wild type and mutated p53 breast cancer epithelial cells by copper and zinc. (2004) (51)
Regulation of the ontogeny of rat liver metallothionein mRNA by zinc. (1987) (51)
Renal metallothionein metabolism after a reduction of renal mass. II. Effect of zinc pretreatment on the renal toxicity and intrarenal accumulation of inorganic mercury. (1992) (51)
The synthesis of metallothionein and cellular adaptation to metal toxicity in primary rat kidney epithelial cell cultures. (1980) (50)
Correlation of parameters of cadmium exposure with onset of cadmium-induced nephropathy in rats. (1984) (49)
Metallothionein and apoptosis during differentiation of myoblasts to myotubes: protection against free radical toxicity. (1999) (49)
Chelation of cadmium with BAL and DTPA in rats (1980) (48)
Metal complexes of dietary flavonoids: evaluation of radical scavenger properties and protective activity against oxidative stress in vivo. (2007) (47)
Effects of cadmium and zinc on tissue levels of metallothionein. (1984) (46)
Effects of acute sodium arsenite administration on the pulmonary chemical metabolizing enzymes, cytochrome P-450 monooxygenase, NAD(P)H:quinone acceptor oxidoreductase and glutathione S-transferase in guinea pig: comparison with effects in liver and kidney. (1993) (45)
Exogenous metallothionein and renal toxicity of cadmium and mercury in rats. (1992) (45)
Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice. (1996) (44)
Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen. (1997) (42)
Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from northern China. (1998) (42)
Adaptive response to ionizing radiation-induced chromosome aberrations in rabbit lymphocytes: effect of pre-exposure to zinc, and copper salts. (1996) (42)
Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. (1996) (42)
Chemical modifications of metallothionein. Preparation and characterization of polymers. (1984) (41)
Effects of gamma radiation on levels of brain metallothionein and lipid peroxidation in transgenic mice. (1998) (41)
Astrocyte cultures from transgenic mice to study the role of metallothionein in cytotoxicity of tert-butyl hydroperoxide. (2000) (40)
Metallothionein and apoptosis in the toxic milk mutant mouse. (1998) (40)
Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors. (1985) (40)
Absorption and tissue distribution of cadmium in mice after chronic feeding with cadmium chloride and cadmium-metallothionein (1983) (38)
The interactions of cis-diamminedichloroplatinum with metallothionein and glutathione in rat liver and kidney. (1990) (38)
Delay of M‐phase onset by aphidicolin can retain the nuclear localization of zinc and metallothionein in 3T3‐L1 fibroblasts (2000) (38)
Signal transduction pathways, and nuclear translocation of zinc and metallothionein during differentiation of myoblasts. (2000) (38)
Biliary excretion of cadmium in rat. V. Effects of structurally related mercaptans on chelation of cadmium from metallothionein. (1982) (38)
Increased radiation-induced apoptosis in mouse thymus in the absence of metallothionein. (1999) (37)
Preparation and properties of six rat hemoglobins. Nonuniform biosynthesis in marrow erythroid cells. (1971) (37)
Biliary excretion of cadmium in rat. II. The role of metallothionein in the hepatobiliary transport of cadmium. (1977) (37)
Toxicology of Metals: Biochemical Aspects (2011) (37)
The influence of manganese on the distribution of essential trace elements. I. Regional distribution of Mn, Na, K, Mg, Zn, Fe, and Cu in rat brain after chronic Mn exposure. (1981) (37)
Formation of lead-induced inclusion bodies in primary rat kidney epithelial cell cultures: effect of actinomycin D and cycloheximide. (1980) (37)
Role of placental metallothionein in maternal to fetal transfer of cadmium in genetically altered mice. (1998) (36)
Renal glutathione depletion and nephrotoxicity of cadmium-metallothionein in rats. (1989) (36)
Endothelin-1–Mediated Alteration of Metallothionein and Trace Metals in the Liver and Kidneys of Chronically Diabetic Rats (2002) (35)
Copper-metallothionein from the toxic milk mutant mouse enhances lipid peroxidation initiated by an organic hydroperoxide. (1994) (34)
Metallothionein induction in human CNS in vitro: neuroprotection from ionizing radiation. (2000) (34)
Chelation of cadmium from metallothionein in vivo and its excretion in rats repeatedly injected with cadmium chloride. (1982) (33)
Zinc- or cadmium-pre-induced metallothionein protects human central nervous system cells and astrocytes from radiation-induced apoptosis. (2004) (33)
Renal metallothionein metabolism after a reduction of renal mass. I. Effect of unilateral nephrectomy and compensatory renal growth on basal and metal-induced renal metallothionein metabolism. (1992) (33)
Ontogenic changes in hepatic metallothionein isoforms in prenatal and newborn rats. (1993) (33)
Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate. (1988) (33)
High-glucose-induced metallothionein expression in endothelial cells: an endothelin-mediated mechanism. (2001) (32)
Environmental exposure to cadmium and factors affecting trace-element metabolism and metal toxicity (1986) (30)
Impaired Hepatic Regeneration in Metallothionein-I/II Knockout Mice After Partial Hepatectomy (2005) (30)
Metallothionein and Its Interaction with Metals (1995) (30)
Pregnancy-Associated Changes in Plasma Metallothionein Concentration and Renal Cadmium Accumulation in Rats (1993) (30)
Mercury-metallothionein and the renal accumulation and handling of mercury. (1993) (30)
Metallothionein induction is not involved in cadmium accumulation in the duodenum of mice and rats fed diets containing high-cadmium rice or sunflower kernels and a marginal supply of zinc, iron, and calcium. (2005) (30)
Uptake of cadmium and metallothionein by rat everted intestinal sacs. (1989) (30)
Metallothionein expression and resistance to cisplatin in a human germ cell tumor cell line. (1995) (29)
Isolation and partial characterization of a mercury-binding nonhistone protein component from rat kidney nuclei. (1973) (28)
Further evidence of the tumor-suppressive effects of cadmium in the B6C3F1 mouse liver and lung: late stage vulnerability of tumors to cadmium and the role of metallothionein. (1993) (28)
Quantification of metallothionein isoforms using an enzyme-linked immunosorbent assay (ELISA) with two specific antisera. (1992) (28)
Induction of renal metallothionein synthesis by parenteral cadmium-thionein in rats. (1978) (28)
The influence of nutritional deficiencies on gastrointestinal uptake of cadmium and cadmium-metallothionein in rats. (1995) (28)
Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder. (2006) (27)
Metallothionein in human gingival amalgam tattoos. (2001) (27)
Characterization studies on the cadmium-binding proteins from two species of New Zealand oysters. (1986) (27)
Regional brain distribution of metallothionein, zinc and copper in toxic milk mutant and transgenic mice. (1997) (27)
Regional distribution of metallothionein, zinc, and copper in the brain of different strains of rats (1999) (27)
Nephrotoxicity of repeated injections of cadmium-metallothionein in rats. (1993) (26)
Heterogeneity of antibodies to metallothionein isomers and development of a simple enzyme-linked immunosorbent assay. (1992) (26)
Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration). (1987) (26)
Metabolic changes in glutathione and metallothionein in newborn rat liver. (1989) (26)
Influence of maternal mineral deficiency on the hepatic metallothionein and zinc in newborn rats. (1986) (25)
Role of metallothionein in human placenta and rats exposed to cadmium. (1992) (25)
Metallothionein expression in renal cancer. (1998) (25)
The interaction of zinc and cadmium in the synthesis of hepatic metallothionein in rats. (1985) (25)
Metallothionein does not protect mouse endocrine cells from damage induced by alloxan injection. (1999) (23)
Cellular localization of metallothionein in the lung following repeated cadmium inhalation. (1985) (23)
Importance of species differences in experimental pulmonary carcinogenicity of inhaled cadmium for extrapolation to humans. (1994) (23)
Ocular copper deposition associated with benign monoclonal gammopathy and hypercupremia. (1996) (22)
CORRELATION BETWEEN CADMIUM-INDUCED PULMONARY CARCINOGENICITY, METALLOTHIONEIN EXPRESSION, AND INFLAMMATORY PROCESSES : A SPECIES COMPARISON (1994) (22)
Changes in dietary zinc result in specific alterations of metallothionein concentrations in newborn rat liver. (1987) (22)
Immunohistochemical localization of metallothionein in human testicular embryonal carcinoma cells (2004) (21)
Renal toxicity of cadmium-metallothionein and enzymuria in rats. (1987) (21)
Augmented hepatic injury followed by impaired regeneration in metallothionein-I/II knockout mice after treatment with thioacetamide. (2006) (21)
Metallothionein induction and pulmonary responses to inhaled cadmium chloride in rats and mice. (1996) (21)
Immunohistochemical Evidence of High Concentrations of Metallothionein in Pancreatic Hepatocytes Induced by Cadmium in Rats (1992) (21)
Expression of functional metallothionein isoforms in papillary thyroid cancer (2009) (21)
Correlation between cadmium-induced pulmonary carcinogenicity, metallothionein expression, and inflammatory processes: a species comparison. (1994) (20)
Site of synthesis of metallothionein in rat liver. (1981) (20)
Zinc supplementation decreases hepatic copper accumulation in LEC rat (2007) (20)
Immunohistochemical localization of metallothionein. (1991) (20)
Effect of ethanol on brain metallothionein in transgenic mice. (2000) (20)
Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass. (1992) (20)
Biological Responses of Elements (2013) (20)
Metabolism of parenterally administered zinc and cadmium in livers of newborn rats. (1983) (19)
Induction of hepatic metallothionein I in tumour-bearing mice. (1995) (19)
The distribution and excretion of manganese: the effects of manganese dose, L-dopa, and pretreatment with zinc. (1982) (19)
Exposure to different forms of cadmium in mice: differences in metallothionein and alphafetoprotein mRNA induction in liver and kidney. (1988) (19)
A spectroscopic study of rat liver and Scylla serrata crab metallothioneins. (1984) (19)
A mutant mouse (tx) with increased hepatic metallothionein stability and accumulation. (1993) (19)
Reduction of copper and metallothionein in toxic milk mice by tetrathiomolybdate, but not deferiprone. (2002) (18)
Selective increase of rat lung cytochrome P450 1A1 dependent monooxygenase activity after acute sodium arsenite administration. (1995) (17)
Sensitivity to radiation treatment and changes in metallothionein synthesis in a transplanted murine tumor. (1997) (17)
Role of metallothioneins in disease. (1978) (17)
The relative importance of glutathione and metallothionein on protection of hepatotoxicity of menadione in rats. (1992) (17)
Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53. (2016) (17)
Influence of chronic MnCl2 and EDTA treatment on tissue levels and urinary excretion of trace metals in rats (1982) (17)
Chelation of cadmium without increased renal cadmium deposition. (1984) (16)
Age dependent changes in metallothionein and accumulation of cadmium in horses. (1989) (15)
Copper-binding proteins in human erythrocytes: Searching for potential biomarkers of copper over-exposure (2003) (15)
A comparative study of the influence of vicinal dithiols and a dithiocarbamate on the biliary excretion of cadmium in rat. (1991) (14)
Biosynthesis and metabolism of metallothionein in rat during perinatal development. (1987) (13)
Developmental changes in hepatic metallothionein, zinc, and copper levels in genetically altered mice. (1998) (13)
Ontogenic changes in hepatic glutathione and metallothionein in rats and the effect of a low-sulphur-containing diet (1990) (12)
A new glycopeptide containing hydroxyproline and sarcosine in human urine. (1965) (12)
Chelation of lead by dimercaptopropane sulfonate and a possible diagnostic use. (1984) (11)
Effects of cadmium-metallothionein on renal organic ion transport and lipid peroxidation in rats. (1988) (11)
Metabolism and potential toxic effects of metallothionein. (1979) (11)
Endothelins and their receptors in cirrhotic and neoplastic livers of Canadian and Chinese populations. (1999) (11)
Comparison of tissue distribution of cadmium in mice intravenously injected with metallothionein and a polymer of metallothionein. (1983) (10)
Cadmium and hypertension (1983) (10)
Induction of metallothionein synthesis with preservation of testicular function in rats following long term renal transplantation (2000) (10)
Effects of zinc deficiency on pre-existing cadmium-metallothionein in the pancreas. (1984) (10)
Lack of luminal or basolateral uptake and transepithelial transport of mercury in isolated perfused proximal tubules exposed to mercury-metallothionein. (1995) (10)
The regional distribution of lead in normal rat brain. (1982) (10)
Liver transplantation induces cytochrome P450 1A1 dependent monooxygenase activity in rat lung and kidney. (1995) (10)
Metallothionein in Cytotoxicity and Genotoxicity of Metals (1997) (9)
Immunohistochemical localization of metallothionein in the developing teeth of cadmium-injected rats. (1999) (9)
Renal effects of repeated administration of calcium disodium ethylenediaminetetraacetate during excessive exposure to lead in rats. (1978) (9)
Rat kidney epithelial cell culture for metal toxicity studies (1985) (9)
Metallothionein as an epithelial proliferative compartment marker for DNA flow cytometry. (1993) (9)
The reaction of metallothionein with mercuribenzoate. A dialysis and 113Cd-n.m.r. study. (1986) (8)
Chelation of lead with DMPS and BAL in rats injected with lead (1983) (8)
Effects of inhibition of cystathionase activity on glutathione and metallothionein levels in the adult rat. (1991) (8)
Turnover of parenterally administered zinc and cadmium and the redistribution of metallothionein bound zinc in newborn rats. (1985) (8)
Radiation exposure does not alter metallothionein III isoform expression in mouse brain (2000) (8)
Role of tumor necrosis factor-alpha in the development of spontaneous hepatic toxicity in Long-Evans Cinnamon rats. (2004) (7)
Studies on toxicity of metallothionein in rat kidney epithelial cell culture. (1982) (5)
Isolation & characterization of a new glycopeptide containing hydroxyproline from human urine. (1966) (5)
Chemical modifications of metallothionein, II. Metabolic fate of cadmium bound to metallothionein polymers. (1985) (5)
Metallothionein and Intracellular Sequestration of Metals (2018) (5)
Biliary excretion of cadmium in rat. III. Effects of chelating agents and change in intracellular thiol content on biliary transport and tissue distribution of cadmium. (1980) (5)
Urinary excretion of hydroxyproline in leprosy. (1969) (3)
Isolation and characterization of metallothionein from guinea pig liver (1986) (3)
The Cellular Accumulation and Subcellular Localization of Metallothionein in Rat Liver During Postnatal Development (1983) (3)
An Evaluation of Methods of Estimation of Metallothionein (1988) (3)
The nuclear-cytoplasmic presence of metallothionein in cells during differentiation and development (1999) (3)
Further studies on the role of metallothionein in the antitumor effects of cadmium (1999) (2)
Effects of dexamethasone injection on body retention and hepatic distribution of zinc, cadmium and metallothionein in newborn rats. (1986) (2)
Plasma MT levels in diabetic and renal failure patients (1999) (2)
Predicting the Kidney Burden of Toxic Metals (1989) (1)
Physicochemical and metabolic properties of modified metallothioneins. (1984) (1)
Glutathione and glutathione-related enzymes in busulfan treated rat lens. (1991) (1)
Biliary excretion of cadmium in rat. VI. Mobilization of cadmium from metallothionein by 2,3-dimercaptopropanol. (1980) (1)
Effect of busulfan on crystalline lens--glutathione, glutathione reductase and glucose-6-phosphate dehydrogenase. (1989) (1)
Metallothionein protein and mRNA in the toxic milk mouse. (1994) (1)
The intestinal adaptive response to iron deficiency increases dietary cadmium absorption in mice and human subjects (1978) (1)
Mouse astrocyte cultures used to study antioxidant property of metallothionein isoforms. (2002) (0)
Metallothionein in toxicology (2016) (0)
Meeting announcements (2004) (0)
Does the measurement of human metallothionein have any potential value in the assessment of cumulative cadmium exposure (1981) (0)
Specific effects of maternal zinc depletion or repletion on the deposition of zinc and metallothionein in newborn rat livers: a longitudinal study (1986) (0)
Preparation and characterization of polymers (2005) (0)
Biological Responses of Elements 9 Monica Nordberg and (2014) (0)
Metallothioneins against metal toxicity and as biomarker in marine organisms (1998) (0)
Investigations of the causes and effects of increased arachidonic 12-lipoxygenase metabolite levels in an intestinal epithelial cell culture model (2010) (0)
Radioimmunoassay of metallothionein in rabbit, rat, mouse, Chinese hamster, and human cells (1991) (0)
PREPARATION AND PROPERTIES OF SIX RAT RED CELL HEMOGLOBINS. (1971) (0)
Nephrotoxic effect of cadmium as cadmium chloride or cadmium metallothionein in renal cortical slices (1986) (0)
Book review (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With M. George Cherian?

M. George Cherian is affiliated with the following schools: